Biogen

BIIBNASDAQ
$224.61
-4.21-1.84%
At Close: -
$224.61
00.00%
After Hours: 1:06 PM EDT
15 minutes delayed
Human Immunology Biosciences was acquired by Biogen (BIIB) on Tuesday, July 2, 2024 for $1.15B

Biogen (NASDAQ:BIIB) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Get Alert
04/24/2024BIIB
Biogen
FY2024$15.00$16.00$15.46Get Alert
02/13/2024BIIB
Biogen
FY2024$15.00$16.00$15.65Get Alert
11/08/2023BIIB
Biogen
FY2023$14.50$15.00$15.29Get Alert
07/25/2023BIIB
Biogen
FY2023$15.00$16.00$15.42Get Alert
04/25/2023BIIB
Biogen
FY2023$15.00$16.00$15.48Get Alert
02/15/2023BIIB
Biogen
FY2023$15.00$16.00$15.72Get Alert
10/25/2022BIIB
Biogen
FY2022$16.50$17.15$16.49$10.00B$10.15B$10.00BGet Alert
07/20/2022BIIB
Biogen
FY2022$15.25$16.75$15.54$9.90B$10.10B$9.84BGet Alert
05/03/2022BIIB
Biogen
FY2022$14.25$16.00$15.44$9.70B$10.00B$9.87BGet Alert
02/03/2022BIIB
Biogen
FY2022$14.25$16.00$18.85$9.70B$10.00B$10.34BGet Alert
10/20/2021BIIB
Biogen
FY2021$18.85$19.35$18.61$10.80B$10.90B$10.76BGet Alert
07/22/2021BIIB
Biogen
FY2021$17.50$19.00$18.59$10.65B$10.85B$10.63BGet Alert
04/22/2021BIIB
Biogen
FY2021$17.50$19.00$18.41$10.45B$10.75B$10.57BGet Alert
02/03/2021BIIB
Biogen
FY2021$17.00$18.50$24.67$10.45B$10.75B$11.22BGet Alert
10/21/2020BIIB
Biogen
FY2020$32.50$33.50$34.77$13.20B$13.40B$13.83BGet Alert
07/22/2020BIIB
Biogen
FY2020$34.00$36.00$32.96$13.80B$14.20B$13.94BGet Alert
01/30/2020BIIB
Biogen
FY2020$31.50$33.50$33.03$14.00B$14.30B$14.06BGet Alert

FAQ

Q

What is the most recent guidance for Biogen (BIIB)?

A

The last reported Earnings numbers were from April 24, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $15.00 and $16.00 versus the estimated EPS of $15.46.

Browse guidance and forecast on all stocks.

People Also Watch